Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$8.97
-0.4%
$9.52
$5.38
$11.04
$180.63M1.43148,606 shs24,653 shs
Inogen, Inc stock logo
INGN
Inogen
$6.53
+2.8%
$6.59
$5.34
$9.13
$177.48M1.6308,950 shs65,756 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$2.70
-0.1%
$3.69
$2.66
$5.92
$44.38M1.0981,428 shs21,231 shs
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
$0.97
-1.2%
$1.08
$0.70
$14.11
$177.26M1.851.87 million shs257,718 shs
Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
0.00%+0.95%+7.13%-6.24%+51.43%
Inogen, Inc stock logo
INGN
Inogen
+4.79%+4.27%-9.54%+1.93%-4.37%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+0.37%-4.93%-12.34%-34.15%-46.00%
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
-0.30%-17.10%+6.07%-53.22%+98,239,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$8.97
-0.4%
$9.52
$5.38
$11.04
$180.63M1.43148,606 shs24,653 shs
Inogen, Inc stock logo
INGN
Inogen
$6.53
+2.8%
$6.59
$5.34
$9.13
$177.48M1.6308,950 shs65,756 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$2.70
-0.1%
$3.69
$2.66
$5.92
$44.38M1.0981,428 shs21,231 shs
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
$0.97
-1.2%
$1.08
$0.70
$14.11
$177.26M1.851.87 million shs257,718 shs
Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
0.00%+0.95%+7.13%-6.24%+51.43%
Inogen, Inc stock logo
INGN
Inogen
+4.79%+4.27%-9.54%+1.93%-4.37%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+0.37%-4.93%-12.34%-34.15%-46.00%
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
-0.30%-17.10%+6.07%-53.22%+98,239,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
2.67
Moderate Buy$15.0067.22% Upside
Inogen, Inc stock logo
INGN
Inogen
2.67
Moderate Buy$14.00114.43% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.57
Moderate Buy$6.88155.01% Upside
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
2.00
Hold$8.00723.89% Upside

Current Analyst Ratings Breakdown

Latest SRTS, INFU, STEX, and INGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/21/2026
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
Lower Price TargetBuy$9.00 ➝ $8.00
5/8/2026
Inogen, Inc stock logo
INGN
Inogen
Reiterated RatingSell (D-)
5/8/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Reiterated RatingBuy
5/1/2026
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
UpgradeSell (E+)Sell (D-)
4/21/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Reiterated RatingSell (D)
4/9/2026
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
Lower Price TargetBuy$12.00 ➝ $9.00
4/7/2026
Inogen, Inc stock logo
INGN
Inogen
UpgradeStrong-Buy
(Data available from 6/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$142.40M1.27$0.70 per share12.79$2.47 per share3.63
Inogen, Inc stock logo
INGN
Inogen
$348.67M0.51N/AN/A$7.08 per share0.92
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$27.48M1.61N/AN/A$2.93 per share0.92
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
$40K4,413.20N/AN/A$0.83 per share1.17
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$870K$0.38149.1928.94N/A1.12%2.78%1.41%N/A
Inogen, Inc stock logo
INGN
Inogen
-$22.75M-$0.91N/AN/AN/A-7.08%-12.90%-8.27%8/6/2026 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$7.72M-$0.47N/AN/AN/A-34.50%-15.79%-14.02%8/6/2026 (Estimated)
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
-$462.77M-$9.71N/AN/AN/AN/A-717.92%-336.75%N/A

Latest SRTS, INFU, STEX, and INGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2026Q1 2026
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
N/A-$0.27N/A-$0.27N/AN/A
5/7/2026Q1 2026
Inogen, Inc stock logo
INGN
Inogen
-$0.24-$0.30-$0.06-$0.30$82.35 million$85.11 million
5/7/2026Q1 2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$0.1250-$0.16-$0.0350-$0.16$5.32 million$3.39 million
3/31/2026Q4 2025
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
N/A-$8.23N/A-$8.23N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
N/AN/AN/AN/AN/A
Inogen, Inc stock logo
INGN
Inogen
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
0.50
1.98
1.59
Inogen, Inc stock logo
INGN
Inogen
N/A
3.10
2.70
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
7.27
4.03
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
N/A
13.90
13.90

Institutional Ownership

CompanyInstitutional Ownership
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
71.13%
Inogen, Inc stock logo
INGN
Inogen
89.94%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
7.16%

Insider Ownership

CompanyInsider Ownership
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
10.80%
Inogen, Inc stock logo
INGN
Inogen
2.50%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
10.20%
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
52.73%
CompanyEmployeesShares OutstandingFree FloatOptionable
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
41020.18 million19.10 millionOptionable
Inogen, Inc stock logo
INGN
Inogen
1,03027.08 million26.40 millionOptionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.46 million14.78 millionOptionable
Biosig Technologies, Inc. stock logo
STEX
Biosig Technologies
50181.80 million85.94 millionN/A

Recent News About These Companies

Biosig Technologies Q1 Earnings Call Highlights
Streamex Corp. Provides May 2026 Shareholder Update
Streamex Corp. (STEX) Q4 2025 Earnings Call Transcript
Streamex Corp.

New MarketBeat Followers Over Time

Media Sentiment Over Time

InfuSystem stock logo

InfuSystem NYSE:INFU

$8.97 -0.04 (-0.44%)
As of 11:35 AM Eastern
This is a fair market value price provided by Massive. Learn more.

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Inogen stock logo

Inogen NASDAQ:INGN

$6.53 +0.18 (+2.82%)
As of 11:36 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$2.70 0.00 (-0.15%)
As of 11:30 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Biosig Technologies stock logo

Biosig Technologies NASDAQ:STEX

$0.97 -0.01 (-1.16%)
As of 11:35 AM Eastern
This is a fair market value price provided by Massive. Learn more.

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.